Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia

NCT00872326 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Vascular Diseases
Diabetic Foot

Interventions

PROCEDURE: Autologous Bone Marrow Mononuclear Cells

Sponsor

Andalusian Network for Design and Translation of Advanced Therapies

Collaborators

[object Object]